FDA lowers starting dose for sleeping aid Lunesta - FOX13 News, WHBQ FOX 13

FDA lowers starting dose for sleeping aid Lunesta

Posted: Updated:

By MATTHEW PERRONE AP Health Writer

WASHINGTON (AP) -- U.S. health officials are lowering the starting dose of the popular sleeping aid drug Lunesta, due to risks of morning drowsiness that can impair driving ability and lead to injury.

The Food and Drug Administration said Thursday it is taking action based on a study that found Lunesta users had problems with driving, memory and coordination up to 11 hours after first taking the drug. Patients are often unaware that they are still drowsy the morning after, according to the FDA, which monitors food and drugs for safety.

The results, published last month, compared 91 patients taking Lunesta or placebo while performing several tasks measuring coordination, memory and other cognitive measures.

Lunesta manufacturer Sunovion Pharmaceuticals, a subsidiary of Japanese drugmaker Dainippon Sumitomo Pharma, will lower the starting dose of the tablet to 1 milligram from currently available 2 milligrams. Patients can increase their dose to 2 or 3 milligrams, but should keep in mind that higher doses are more likely to cause next-day impairment, according to the FDA statement.

Patients currently taking 2 or 3 milligram doses of Lunesta should contact their doctor to get information about the most appropriate dose.

Drowsiness is a side effect listed on the labels of all anti-insomnia drugs, the agency release notes.

Thursday's announcement follows a similar FDA action last year that reduced the dosage of Ambien and other generic insomnia drugs containing the ingredient zolpidem. Those drugs are the most widely prescribed sleep aids in the U.S. Lunesta uses a different active ingredient called eszopiclone.

"Recently, data from clinical trials and other types of studies have become available, which allowed the FDA to better characterize the risk of next-morning impairment with sleep drugs," the FDA's Dr. Ellis Unger said in a statement.

Lunesta, launched in 2005, is designed to be taken before bed to help patients with insomnia fall asleep and stay asleep for up to 7 hours.

Calls to Sunovion Pharmaceuticals Inc. were not immediately returned Thursday afternoon.

Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

  • HealthMore>>

  • Diabetes Patients May Face Higher Risk of Head, Neck Cancers

    Diabetes Patients May Face Higher Risk of Head, Neck Cancers

    Diabetes Patients May Face Higher Risk of Head, Neck Cancers Head and neck cancers were more common in diabetes patients in recent study (dailyRx News) Diabetes is known to increase many health risks like heart...
    Diabetes Patients May Face Higher Risk of Head, Neck Cancers Head and neck cancers were more common in diabetes patients in recent study (dailyRx News) Diabetes is known to increase many health risks like...
  • Many Seniors Had Multiple Chronic Illnesses

    Many Seniors Had Multiple Chronic Illnesses

    Many Seniors Had Multiple Chronic Illnesses Life expectancy decreased with diagnosis of each additional condition (dailyRx News) Many older Americans deal with more than one serious medical condition at a time. New...
    Many Seniors Had Multiple Chronic Illnesses Life expectancy decreased with diagnosis of each additional condition (dailyRx News) Many older Americans deal with more than one serious medical condition at a...
  • Irregular Shift Work May Be Linked to Diabetes

    Irregular Shift Work May Be Linked to Diabetes

    Irregular Shift Work May Be Linked to Diabetes Diabetes risk increased especially in men who worked rotating or night shifts (dailyRx News) People who work the graveyard shift may have bigger health problems to...
    Irregular Shift Work May Be Linked to Diabetes Diabetes risk increased especially in men who worked rotating or night shifts (dailyRx News) People who work the graveyard shift may have bigger health...
Powered by WorldNow

WHBQ-TV | Fox 13
485 S. Highland St.
Memphis, TN 38111

Main Station: (901) 320-1313
Newsroom: (901) 320-1340

Didn't find what you were looking for?
All content © Copyright 2000 - 2014 Fox Television Stations, Inc. and Worldnow. All Rights Reserved.
Privacy Policy | Terms of Service | Ad Choices